Personal Profile
Professor Brady’s major specialities are the clinical aspects and epidemiology of hypertension, coronary heart disease and pulmonary embolism. He was the principal investigator in four major UK studies (totalling 140,000 patients). He was the Principal Investigator for the UK in the IMPROVE-IT trial (TIMI 40) in acute coronary syndromes (ACS), and currently the KONA WAVE trial in renal denervation. He has also published and specialises in atrial fibrillation, heart failure and valvular heart disease, together with >30 years’ experience as a cardiologist.
Professor Brady has published >100 papers in medical research journals on the above subjects and also in basic cardiovascular biology. His textbook, “New Perspectives on Hypertension,” is now in its third edition. A second textbook, “An Atlas of Diabetes and Cardiovascular Disease,” is nearing completion. He is the Principal author of the Hypertension section of the current 2020 Mayo Clinic Textbook of Cardiology.
Professor Brady has given over >200 invited national and international lectures including Plenary lectures at the European Society of Cardiology (ESC), the European Atherosclerosis Society, the American Heart Association, the Japanese Circulation Society, the French Cardiac Society, the National Societies of South Korea, Chile, Portugal, Hong Kong, Thailand, Norway, Denmark, Croatia, Slovenia, Lithuania and Egypt, the World Congress of Cardiology and the Mayo Clinic. Professor Brady represented the ESC on a lecture tour of China.
Professor Brady was elected a Fellow of the American Heart Association in 2003, and the ESC in 2011. He is the Past President of the British and Irish Hypertension Society, Visiting Professor of Cardiology at the Mayo Clinic, Minnesota, USA and Visiting Professor of Cardiology at the Cleveland Clinic, Ohio, USA: visiting Professor of Cardiology at the University of Valparaiso, Honorary Fellow of the Hong Kong College of Cardiology, and Honorary Member of the Korean Society of Cardiology.
He is past Chairman of the Guidelines Committee of the British Cardiovascular Society, and represented the UK on the ESC Guidelines Development Group. Professor Brady was a principal author of the 2007 Scottish National Guideline for Coronary Heart Disease, the 2008 ESC Guideline on Pulmonary Embolism, and the 2010 SIGN Guideline for Venous Thromboembolism (VTE). He will chair the forthcoming 2021 SIGN Guideline for VTE.
In 2018 Professor Brady was honoured to present the Medical Grand Rounds at both the Mayo Clinic and the Cleveland Clinic, America’s leading hospitals. He returned to the Cleveland Clinic in 2019 as part of Nephrology 2019 Update.
Currently, Professor Brady is the Global Spokesperson on Hypertension issues for the ESC. He conceived, developed and led the acclaimed Football Health Scotland study of dietary and lifestyle therapy in middle-aged men. Professor Brady is the clinical lead for this Scotland-wide project, linking football and health across the nation. His Channel 4 television programme about diet and blood pressure was screened in 2018.
